Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
4Tissue from Gent, company number BE0799669186, closed financial year 2025 with a result of € -727,036 after tax. For that financial year 4Tissue recorded a gross margin of € 327,753 and equity of € 845,476. Compared with financial year 2024, the result moved from € -321,213 to € -727,036. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ 845,476
▲ 48% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -727,036
▼ 126 % more loss than in 2024
Profit after tax over the fiscal year.
€ 122,182
▼ 84% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.1 million.
People and assets in 2025
€ 309,690
▲ € 277,856 vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 140,970
▲ 245% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 37,804
▲ € 34,243 vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -21,045 | € -113,482 | € 327,753 | ▲ € 441,234 |
| Profit after taxes | € -21,074 | € -321,213 | € -727,036 | ▼ € 405,823 |
| Equity | € -6,074 | € 572,712 | € 845,476 | ▲ 48% |
| Total debts | € 12,399 | € 1,031,854 | € 1,713,793 | ▲ 66% |
| Cash | € 3,940 | € 771,689 | € 122,182 | ▼ 84% |
| Retained profit | € -21,074 | € -342,288 | € -1,069,324 | ▼ € 727,036 |
| Balance sheet total | € 6,325 | € 1,604,566 | € 2,559,270 | ▲ 59% |
Key figures of 4Tissue, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to 4Tissue?
What happened at 4Tissue in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 727,036. Source: NBB ↗
- Robium BV stepped down as director. NBB
- Benoit Moreaux BV stepped down as director. NBB
- Anne Van de casteele became a director. NBB
- Bernard Depypere became a director. NBB
- Lawoti BV became a director. NBB
- Lana Van Damme became a director. NBB
- Phillip Blondeel became a director. NBB
In short
From € 21,074 loss in 2023 to € 727,036 loss in 2025.
Management
Behind 4Tissue are SAS KBK BO, Anne Van de casteele, Bernard Depypere, Lawoti BV, Lana Van Damme and Phillip Blondeel. Bernard Depypere is also behind International Breast Clinic.
Directors
According to the 2025 annual accounts
Director · represented by katleen verleysen
Anne Van de casteele
Director
since 2024
since 2024
Director · represented by Koen Iterbeke
since 2024
Lana Van Damme
Director
since 2024
Phillip Blondeel
Director
Also active at: Lareon, Laboratorium voor Restauratie en Conservatie Onderzoek
since 2024
Sandra Van Vlierberghe
Director
since 2024
Director · represented by Benoit Christian Moreaux
since 2024 · until 2025
Director · represented by An Van Den Bulcke
since 2024 · until 2025
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 48
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0799.669.186
- VAT number
- BE 0799.669.186
- Registered office
- Technologiepark-Zwijnaarde 48, 9052 Gent
- Names & denominations
- 4Tissue
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 March 2023
- Peppol
- Active · Active since 20 Nov 2025
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Overige gespecialiseerde wetenschappelijke en technische activiteiten